DE69024060D1 - Osteogenesis-stimulierende mittel. - Google Patents

Osteogenesis-stimulierende mittel.

Info

Publication number
DE69024060D1
DE69024060D1 DE69024060T DE69024060T DE69024060D1 DE 69024060 D1 DE69024060 D1 DE 69024060D1 DE 69024060 T DE69024060 T DE 69024060T DE 69024060 T DE69024060 T DE 69024060T DE 69024060 D1 DE69024060 D1 DE 69024060D1
Authority
DE
Germany
Prior art keywords
osteogenesis
stimulating agents
carnosine
complex
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69024060T
Other languages
English (en)
Other versions
DE69024060T2 (de
Inventor
Masayoshi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Original Assignee
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd, Zeria Pharmaceutical Co Ltd filed Critical Hamari Chemicals Ltd
Application granted granted Critical
Publication of DE69024060D1 publication Critical patent/DE69024060D1/de
Publication of DE69024060T2 publication Critical patent/DE69024060T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69024060T 1989-10-02 1990-09-28 Osteogenesis-stimulierende mittel. Expired - Fee Related DE69024060T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1255325A JP2811331B2 (ja) 1989-10-02 1989-10-02 骨形成促進剤
PCT/JP1990/001255 WO1991004737A1 (fr) 1989-10-02 1990-09-28 Promoteur d'osteogenese

Publications (2)

Publication Number Publication Date
DE69024060D1 true DE69024060D1 (de) 1996-01-18
DE69024060T2 DE69024060T2 (de) 1996-08-01

Family

ID=17277215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024060T Expired - Fee Related DE69024060T2 (de) 1989-10-02 1990-09-28 Osteogenesis-stimulierende mittel.

Country Status (8)

Country Link
US (1) US5294634A (de)
EP (1) EP0495106B1 (de)
JP (1) JP2811331B2 (de)
KR (1) KR0147855B1 (de)
AT (1) ATE131047T1 (de)
CA (1) CA2067374C (de)
DE (1) DE69024060T2 (de)
WO (1) WO1991004737A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2811353B2 (ja) * 1990-07-06 1998-10-15 ゼリア新薬工業株式会社 炎症性腸疾患予防・治療剤
US20020150629A1 (en) * 2000-05-31 2002-10-17 Yasuhiro Nishimura Zinc-supplementary compositions for oral administration
CN102802685B (zh) 2009-11-25 2015-05-27 扩散技术公司 用抗微生物金属离子对掺杂沸石的塑料的后加载
US8821912B2 (en) 2009-12-11 2014-09-02 Difusion Technologies, Inc. Method of manufacturing antimicrobial implants of polyetheretherketone
EP2523672B1 (de) 2010-01-15 2016-07-13 Rutgers, the State University of New Jersey Verwendung von vanadiumverbindungen für beschleunigte knochenheilung
CN102946912B (zh) 2010-05-07 2017-09-08 扩散技术公司 具有增强的亲水性的医学植入物
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
KR20140048076A (ko) 2010-12-10 2014-04-23 유니버시티 오브 메디신 앤드 덴티스트리 오브 뉴 저지 인슐린 모사 제제 복합재로 코팅된 생체 매립가능한 장치 및 이의 방법
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63229058A (ja) * 1987-03-17 1988-09-22 大鳥　泰雅 骨形成材料の製法
JPH0717505B2 (ja) * 1989-02-23 1995-03-01 絹子 永井 骨粗鬆症予防剤

Also Published As

Publication number Publication date
EP0495106B1 (de) 1995-12-06
JPH03120257A (ja) 1991-05-22
JP2811331B2 (ja) 1998-10-15
WO1991004737A1 (fr) 1991-04-18
DE69024060T2 (de) 1996-08-01
ATE131047T1 (de) 1995-12-15
KR0147855B1 (ko) 1998-08-17
EP0495106A1 (de) 1992-07-22
US5294634A (en) 1994-03-15
KR920703050A (ko) 1992-12-17
CA2067374A1 (en) 1991-04-03
CA2067374C (en) 2000-07-04
EP0495106A4 (en) 1992-09-30

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
TW234691B (de)
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
IL80437A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
DE59309714D1 (de) Pharmazeutische und/oder kosmetische Zubereitung
EP0620004A4 (de) Medizinische zusammensetzung.
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
DE68907566D1 (de) Phenoxy- und phenylthio-, amino-substituierte benzocyclo-alkan-derivate bei der behandlung und verhuetung von arzneimittelresistenten protozoen-infektionen.
ES8707553A1 (es) Procedimiento para la obtencion de un peptido.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
FR2579463B1 (fr) Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
IT1216103B (it) Peptidi ad attivita' farmaceutica.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
EP0448726A4 (en) 2-substituted 2-cyclopentenone and carcinostatic agent and osteogenesis promoter containing the same as active ingredient
ATE15645T1 (de) Als aktiven zusatz alpha-benzylapfelsaeure enthaltende immunomodulatoren.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee